These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3101004)

  • 1. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibitory activity of spiramycin against Haemophilus influenzae.
    Dabernat H; Delmas C
    Chemioterapia; 1987 Jun; 6(2 Suppl):158-9. PubMed ID: 3509933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of roxithromycin against respiratory and skin pathogens.
    Pechére JC; Auckenthaler R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA; Knothe H; Koulen G
    Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility studies with josamycin and erythromycin.
    Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
    Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriostatic effect of tetracyclines-macrolides associations].
    de Lajudie P
    Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
    Marks MI
    Can Med Assoc J; 1975 Jan; 112(2):170-3. PubMed ID: 234287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in general practice.
    Hammond L
    Aust Fam Physician; 1990 May; 19(5):723-4, 727, 730-1. PubMed ID: 2111984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carbon dioxide upon the in vitro activity of erythromycin.
    Dibb WL; Digranes A; Bottolfsen KL
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):173-6. PubMed ID: 3090858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.